Your browser doesn't support javascript.
loading
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
Dychter, Samuel S; Harrigan, Rena; Bahn, Jesse D; Printz, Marie A; Sugarman, Barry J; DeNoia, Emanuel; Haughey, David B; Fellows, Daniel; Maneval, Daniel C.
Afiliação
  • Dychter SS; Halozyme Therapeutics, Inc, San Diego, California. Electronic address: sdychter@halozyme.com.
  • Harrigan R; Halozyme Therapeutics, Inc, San Diego, California.
  • Bahn JD; Halozyme Therapeutics, Inc, San Diego, California.
  • Printz MA; Halozyme Therapeutics, Inc, San Diego, California.
  • Sugarman BJ; Halozyme Therapeutics, Inc, San Diego, California.
  • DeNoia E; ICON Development Solutions, San Antonio, Texas.
  • Haughey DB; ICON Development Solutions, Whitesboro, New York.
  • Fellows D; ICON Development Solutions, Whitesboro, New York.
  • Maneval DC; Halozyme Therapeutics, Inc, San Diego, California.
Clin Ther ; 36(2): 211-24, 2014 Feb 01.
Article em En | MEDLINE | ID: mdl-24486335
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Ondansetron / Hialuronoglucosaminidase Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Ondansetron / Hialuronoglucosaminidase Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Ano de publicação: 2014 Tipo de documento: Article